-
Document de presse | 2020.04.24
Development and evaluation of four serological assays to detect SARS-CoV-2 antibodies and two assays to detect neutralizing antibodies
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December 2019, COVID-19 had become a major pandemic threat. By April 12, 2020, around half of the world's population was in lockdown, with 1.8 million officially diagnosed cases. Scientists from the Institut Pasteur, the CNRS, Inserm and Université de Paris conducted a pilot study to...
-
Document de presse | 2016.01.07
University of Maryland School of Medicine researcher Jacques Ravel receives prestigious international science award
Research Focuses on the Intersection of Women’s Health and the Microbiome Jacques Ravel, PhD, Professor of Microbiology and Immunology, as well as Associate Director for Genomics at the Institute for Genome Sciences (IGS), both at the University of Maryland School of Medicine, has been named a 2015-2017 Blaise Pascal International Research Chair, one of the most prestigious European science...
-
Document de presse | 2015.05.25
Kurma Partners announces the launch of its third fund Kurma Diagnostics (KDx)
The European Investment Fund (EIF), Fonds National d’Amorçage (FNA) managed by Bpifrance as part of the French government’s Investments for the future (“Investissements d’Avenir”) program, Institut Pasteur, and BNP Paribas are participating in the first closing (€33M). Press release Paris, May 26, 2015 Kurma Diagnostics: the first Venture Capital...
-
Document de presse | 2013.12.18
Molecular marker discovered for detecting artemisinin-resistant forms of malaria
Scientists at the Institut Pasteur in Paris, the Institut Pasteur in Cambodia, the French National Center for Scientific Research (CNRS), and the U.S. National Institutes of Health (NIAID/NIH) have identified a molecular marker for detecting malaria parasites with resistance to artemisinin derivatives (major components in antimalarial medicine or drug treatments currently recommended by the World...
-
Document de presse | 2013.02.06
Treatment of Cutaneous Leishmaniasis: Study of Phase III Shows Antibiotic Cream Has High Cure Rate, Few Side Effects
An international research partnership from Tunisia, France and the United States has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an antibiotic cream. CL is a parasitic disease that causes disfiguring lesions and affects 1.5 million people worldwide annually, including the socio-economically disadvantaged in the...
-
Document de presse | 2008.10.05
Nobel Prize in Medicine 2008 awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier
The Nobel Prize in Medicine 2008 has been awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier for their discovery of the human immunodeficiency (AIDS) virus in 1983 at the Institut Pasteur, and to Prof. Harald zur Hausen for his discovery of the human papillomavirus, which is responsible for cervical cancer. Press releaseParis, october 6, 2008 “Twenty five...
-
Document de presse | 2013.11.04
Two European programs reinforce the fight against emerging diseases
The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and...
-
Document de presse | 2016.11.04
Malaria – Discovery of a molecular marker associated with piperaquine resistance in parasites
A collaborative project conducted by scientists from the Institut Pasteur in Cambodia, the Institut Pasteur in Paris, the Institut Cochin, the Laboratory of Applied Mathematics at Paris Descartes University, Columbia University (New York, USA) and the National Malaria Control Program in Cambodia has identified a molecular marker able to detect Plasmodium falciparum malaria parasites resistant to...
-
Document de presse | 2019.01.24
The new Institut Pasteur strategic plan for 2019-2023
After taking office as President of the Institut Pasteur in January 2018, Professor Stewart Cole embarked on the development of a new strategic plan for the Institut Pasteur for the period 2019-2023. On December 21, 2018, the Board of Directors unanimously adopted this ambitious yet realistic action plan for the next five years.Three priority scientific areas have been identified: • emerging...
-
News | 2020.02.18
The Chinese Ambassador to France visits the Institut Pasteur
On Friday February 14, 2020, Stewart Cole, President of the Institut Pasteur, played host to His Excellency Mr Lu Shaye, Chinese Ambassador to France, who was visiting the Institut Pasteur to show support both personally and on behalf of his country for the Institut Pasteur’s efforts in response to the novel coronavirus outbreak. The visit provided an opportunity to introduce the ambassador and...